Ireland
--:--IST
Latest
Clinical Trials in Israel / NCT04287283
Active, not recruiting Observational

Cognitive Profile of Patients at the Sagol Center for Hyperbaric Medicine and Research

NCT04287283 · tracked via the Priya Life Science Israel tracker
Phase
Observational
Started
2008-01
Last updated
2026-04-21

Condition(s) studied

TBI (Traumatic Brain Injury)StrokeFibromyalgiaAging

Investigational drug(s) / intervention(s)

Hyperbaric Oxygen

Hyperbaric Oxygen: 40-60 daily hyperbaric sessions, 5 days per week. Each session consists of 90 minutes exposure to 100% oxygen at 1.5-2 ATA.

Study summary

In the investigator's institute there is ongoing treatment of different patients with cognitive deficits using Hyperbaric oxygen therapy (HBOT). These patients undergo neuro-cognitive function computerized tests before and after treatment.

The aim of this study was to retrospectively evaluate the cognitive changes before and after HBOT in different patients populations.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients included if they completed at least two neuro-cognitive computerized tests, before and after HBOT Exclusion Criteria: * Patients who were not able to complete two cognitive tests

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
hyperbaric center Asaf harofe medical center Rishon LeZiyyon Israel

More Assaf-Harofeh Medical Center trials in Israel

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04287283 on ClinicalTrials.gov ↗ ← All trials in Israel